<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03464747</url>
  </required_header>
  <id_info>
    <org_study_id>IRB : 16.09.02</org_study_id>
    <nct_id>NCT03464747</nct_id>
  </id_info>
  <brief_title>Continuous Central Venous Lactate Monitoring by Intravascular Microdialysis : a Comparison to Sequential Arterial Lactate Measurement During Shock.</brief_title>
  <official_title>Continuous Central Venous Lactate Monitoring by Intravascular Microdialysis : a Comparison to Sequential Arterial Lactate Measurement During Shock.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During shock, arterial hypotension, inadequate cardiac output and microcirculatory
      alterations lead to tissue hypoxia, multiple organ failure and death. Arterial lactate is
      considered as the best marker of tissue hypoxia. A lactate decrease during the first 6 hour
      is strongly associated with better outcome and may be used as a target for assessing the
      efficiency of shock resuscitation.

      The EIRUS system (Maquet Critical Care AB, 17154, Solna, Sweden) is a new device allowing the
      continuous measurement of venous lactate through a central venous catheter.

      However, before being used extensively, such device needs to be evaluated concerning its
      accuracy. The aim of the present study is to assess the reliability of this device.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 17, 2017</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Agreement</measure>
    <time_frame>Every 4hours for 48hours</time_frame>
    <description>Agreement between sequential arterial blood lactate measurement and continuous venous lactate obtained by microdialysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Interchangeability</measure>
    <time_frame>Every 4hours for 48hours</time_frame>
    <description>Interchangeability of the variations of the two methods using the trend interchangeability method</description>
  </secondary_outcome>
  <enrollment type="Anticipated">33</enrollment>
  <condition>Shock</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EIRUS system (Maquet Critical Care AB, 17154, Solna, Sweden)</intervention_name>
    <description>continuous measurement of venous lactate through a central venous catheter by microdialysis</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        ICU patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Acute circulatory failure defined as : systolic blood pressure&lt;90mmHg or mean arterial
        pressure &lt;65mmHg and blood lactate &gt; 2mmol/L

        Exclusion Criteria: Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Claire Roger, MD, PhD</last_name>
    <phone>+334666686819</phone>
    <email>claire.roger@chu-nimes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aurélien Daurat, MD</last_name>
    <phone>+33466687743</phone>
    <email>aurelien.daurat@chu-nimes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes Cedex 9</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jean Yves Lefrant, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2018</study_first_submitted>
  <study_first_submitted_qc>March 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2018</study_first_posted>
  <last_update_submitted>March 8, 2018</last_update_submitted>
  <last_update_submitted_qc>March 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lactic Acid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

